Table of Contents Table of Contents
Previous Page  50 / 61 Next Page
Information
Show Menu
Previous Page 50 / 61 Next Page
Page Background

1

st

line NSCLC: IO Positive Ph3 trials to date

IO alone

KN-024

IO + CT

KN-189

Impower 150

IO + IO

CM 227

Stage III after

chemorads

PACIFIC

+

=

More and more patients will get IO before 2

nd

line